US biotech firms grow more secretive amid rising competition from Chinese industry
read at Endpoints ↗Negative
US biotech companies are becoming more secretive as competition from China’s rapidly expanding biotech sector intensifies.
Janine Sengstack, a senior scientist at Junevity, says her team may have identified a breakthrough approach for diabetes and obesity by repressing specific genes after screening hundreds of candidates.
The article notes that increased secrecy could limit collaboration and affect how investors access information about U.S. drug development.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “US biotechs turn secretive as they fear competition from rising Chinese industry”
read at Endpoints ↗84 words · retrieved Jul 10
comments(0)
5-min edit window · permanent after that